Filter
196
Filtered Results: 196
Text search:
Müller,
O
Featured
Recommendations
25
New Publications
24
Language
Document type
No document type
83
Guidelines
53
Studies & Reports
41
Manuals
10
Strategic & Response Plan
4
Training Material
3
Situation Updates
2
Countries / Regions
Global
12
Russia
10
South Africa
8
Latin America and the Carribbean
6
Germany
4
Ukraine
4
Western and Central Europe
4
Eastern Europe
4
India
3
Indonesia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
USA
2
Uganda
2
Philippines
2
South Sudan
2
Syria
2
Kenya
2
Rwanda
2
Mozambique
2
Argentina
2
Yemen
2
West and Central Africa
2
Congo, Democratic Republic of
1
Mali
1
Nepal
1
Zambia
1
Cambodia
1
Sudan
1
Benin
1
Brazil
1
Angola
1
Lesotho
1
East and Southern Africa
1
Paraguay
1
Africa
1
Venezuela
1
Vietnam
1
France
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
56
Clinical Guidelines
18
Pharmacy & Technologies
6
Women & Child Health
4
Public Health
2
Key Resources
2
Toolboxes
COVID-19
39
Mental Health
23
AMR
18
HIV
11
Planetary Health
10
TB
8
NTDs
8
Disability
7
Rapid Response
5
Caregiver
4
Pharmacy
4
Health Financing Toolbox
3
Ebola
2
Refugee
2
Global Health Education
2
NCDs
2
Cholera
1
Specific Hazards
1
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current C...
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prev...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, p...
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers an...
A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021
recommended
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and ...thers, representing all WHO regions, with the understanding that the definition may change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.
Клиническое определение случая состояния после COVID-19 методом дельфийского консенсуса, 6 октября 2021 г.
recommended
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and ...thers, representing all WHO regions, with the understanding that the definition may change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most ...f these diseases and conditions are at least partially caused by the environment. It was estimated in 2012 that 26% of childhood deaths and 25% of the total disease burden in children under five could be prevented through the reduction of environmental risks such as air pollution, unsafe water, sanitation and inadequate hygiene or chemicals.
This Strategy and Plan of Action on Health Promotion within the Context of the Sustainable Development
Goals 2019-2030 seeks to renew health promo...
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending ...n health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (including their health spending on COVID-19) and an analysis of high-income countries spending patterns, in particular during the global financial crisis. The report also points out the need for more public investment in health to get progress towards UHC back on track and strong health security.
This review examines high-quality research evidence that synthesises the efects of extreme heat on human health in tropical
Africa. Web of Science...
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to o<...
With the recent advances in medicine, the survival rate of clients with
severe burns has improved. This has resulted in greater demand for rehabilitation services. One ...f the major goals for rehabilitation programmes is to restore these clients to their pre-trauma activity levels. However, there is not much research on the subject.
ECDC Technical Report, Fourth Update 3 July 2020
As this report shows,
reports of child abuse and of children
witnessing violence between their
parents and caregivers have increased.
Ending violence against children is
increasingly within ...ur reach. D
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances,...
